Articles: chronic.
-
ILD Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Amyloidosis is the abnormal formation of proteins, amyloid fibrins. It is characterised by extracellular deposition in various organs. Pulmonary amyloidosis is rare and can present in the forms of laryngeal, tracheobronchial, pulmonary and mediastinal lymph node disease (1). We present a case of nodular pulmonary amyloidosis in a patient with MCTD. ⋯ Pulmonary amyloidosis is a rare complication of MCTD. Though radiological features can be distinguishing, tissue diagnosis is still the gold standard.Reference #1: Rajagola S, Singh N, Gupta K et al. Pulmonary amyloidosis in Sjogren's Syndrome: A case report and a systemic review of the literature. Respirology (2010) 15, 860-868Reference #2: Ito I, Nagai S, Kitaichi M et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am. J. Respir. Crit. Care Med. 2005; 171: 632-8.Reference #3: Aylwin AC, Gishen P, Copley SJ. Imaging appearance of thoracic amyloidosis. J Thorac Imaging 2005;20(1):41-46DISCLOSURE: The following authors have nothing to disclose: Chuen Peng Lee, Ser Hon Puah, Wenyuan Sim, Mark Tien, Jessica Pau, Grace Tan, Ruth ChangNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is one of the most important problems. Previous reports suggested that systemic inflammation may be the link between COPD and comorbidities, but this issue is still low debated in Japan. Whatever the mechanism of comorbidities may be, it has important clinical, prognostic and therapeutic problems. In this study, investigated for the evaluation and measures about COPD burden patients of the current situation in rural area Japan. And also aimed that through comorbidities, contributes to improving patients care and COPD awareness. ⋯ The following authors have nothing to disclose: Tomoyasu UnoNo Product/Research Disclosure Information.
-
COPD Rehabilitation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: In elderly patients the association between chronic obstructive pulmonary disease (COPD) and ischemic heart disease (IHD) is common and predisposes to severe complications and marked restrictions of daily activity. The aim was to evaluate the results of exercise training of the rehabilitation programs in patients with mild or moderate COPD and stable chronic ischemic heart disease (CIHD). ⋯ The following authors have nothing to disclose: Corina Cozma Dima, Clementina Doina Cojocaru, Paraschiva PostolacheNo Product/Research Disclosure Information.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The purpose of our work is to determine the profile of patients most likely to develop these episodes taking into account obstructive airway problems such as asthma or COPD as the most common and therefore investigated the airway eosinophilic inflammation (asthma type cough and eosinophilic bronchitis) as well as active smoking or the presence of chronic airflow obstruction (CAO). ⋯ The following authors have nothing to disclose: Carolina Gotera, Carolina Jurkojc Mohremberger, Adalberto PachecoNo Product/Research Disclosure Information.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: FeNO (fractional exhaled nitric oxide) may help identify cases of NAEB (nonasthmatic eosinophilic bronchitis) or asthma. The aim of this study is to evaluate the utility of FeNO in the evaluation of chronic cough ⋯ The following authors have nothing to disclose: Vijo PouloseNo Product/Research Disclosure Information.